Schneider Electric , a global energy technology leader, and Deloitte , a leading professional services organization, today announced a collaboration to help customers and clients — from ...

Bioretec Ltd Notice to general meeting 20 April 2026 at 4:30 p.m. EEST. The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 8 May 2026 ...

ROBIT PLC STOCK EXCHANGE RELEASE 20 APRIL 2026 AT 2.00 P.M. ROBIT PLC INTERIM REPORT 1 JANUARY–31 MARCH 2026: RECEIVED ORDERS INCREASED AND PROFITABILITY IMPROVED SIGNIFICANTLY.

CITYCON OYJ Stock Exchange Release 20 April 2026 at 16:10 hrs. Citycon Oyj's Annual General Meeting took place today, 20 April 2026. The Annual General Meeting was held at Eteläe ...

To further promote the alignment of cultural industry resources and deepen cooperation between Jiangsu and Hong Kong and Macao, the "Splendid Jiangsu Cultural Exchange and Industrial Promotion Event" ...

Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce it has entered into an earn-in agreement with Qstone Inc., a private Guyanese company, pursuant to which Fortuna may earn up to a 70% ...

Finland offers excellent circumstances for green industries, as it has low electricity prices, a highly reliable grid and comparably fast grid connections. Power procurement for new industrial ...

Bodor Laser has ranked No. 1 globally in sales of laser cutting machines (1,000W and above) for the seventh consecutive year, according to data released by Qianzhan Industry Research Institute in ...

Project Patache will be Copenhagen Infrastructure Partners’ second large-scale battery energy storage system (BESS) in Chile, reinforcing CIP’s commitment to delivering critical new energy ...

Long-term services agreement of approximately US$300 million over the term of the agreement will provide Vista fleet with cost-predictability and essential peace-of-mind Agreement centered on ...

ROBIT PLC PRESS RELEASE 20 APRIL 2026 AT 2.15 P.M. RECEIVED ORDERS INCREASED AND PROFITABILITY IMPROVED SIGNIFICANTLY. Sales efforts implemented in recent months had a positive im ...

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner Advancing felzartamab – a CD38-directed ...